Liver Disease in Patients on Total Parenteral Nutrition

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

Parenteral nutrition-associated liver disease (PNALD) spectrum ranges from liver enzyme abnormalities to steatosis to fibrosis, and, eventually, cirrhosis from total parenteral nutrition (TPN). The pathophysiology is postulated to be multifactorial. Diagnosis in adults is primarily by exclusion, eliminating other causes of chronic liver disease or cirrhosis, and other factors seen in critically ill or postoperative patients on TPN. Principal treatment is avoiding TPN. If this is not feasible, research supports fish oil–based lipid emulsions in TPN formulations to reduce risk and progression of PNALD. With liver and intestinal failure, liver and intestine transplant is an option.

Original languageEnglish (US)
Pages (from-to)687-695
Number of pages9
JournalClinics in liver disease
Volume21
Issue number4
DOIs
StatePublished - Nov 2017

Keywords

  • Cholestasis of sepsis
  • Combined intestinal and liver failure
  • PNALD
  • TPN

ASJC Scopus subject areas

  • Hepatology

Fingerprint

Dive into the research topics of 'Liver Disease in Patients on Total Parenteral Nutrition'. Together they form a unique fingerprint.

Cite this